Are pANCA, ASCA, or Cytokine Gene Polymorphisms Associated with Pouchitis? Long-term Follow-up in 102 Ulcerative Colitis Patients
暂无分享,去创建一个
C. Bodian | S. Plevy | D. Sachar | R. Hegazi | N. Nilubol | J. Aisenberg | Gena M Cobrin | J. Bauer | S. Gorfine | S. Ellozy | P. Legnani | J. Yager
[1] S. Targan,et al. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: Ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis , 1995, Journal of Clinical Immunology.
[2] N. Harpaz,et al. Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis , 1995, Digestive Diseases and Sciences.
[3] F. Nagengast,et al. Postoperative and long-term results of ileal pouch-anal anastomosis for ulcerative colitis and familial polyposis coli , 1992, Digestive Diseases and Sciences.
[4] A. Blakemore,et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat , 1993, Human Genetics.
[5] M. T. Abreu-Martin,et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis , 2001, Gut.
[6] A. Cox,et al. The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. , 2001, Gastroenterology.
[7] P. Brigidi,et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.
[8] R. Thirlby,et al. Risk Factors and True Incidence of Pouchitis in Patients after Ileal Pouch–Anal Anastomoses , 2000, World Journal of Surgery.
[9] B. Vainer,et al. Established and emerging biological activity markers of inflammatory bowel disease. , 2000, The American journal of gastroenterology.
[10] B. Vainer,et al. Clinical Reviews , 2000, American Journal of Gastroenterology.
[11] Huiying Yang,et al. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. , 1999, Gastroenterology.
[12] S. Targan,et al. Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications , 1999, Diseases of the colon and rectum.
[13] S. Targan,et al. Linkage of Crohn’s disease to the major histocompatibility complex region is detected by multiple non-parametric analyses , 1999, Gut.
[14] F. Casellas,et al. Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies. , 1999, European journal of gastroenterology & hepatology.
[15] W. Sandborn,et al. Is antibody testing for inflammatory bowel disease clinically useful? , 1999, Gastroenterology.
[16] S. Targan. The utility of ANCA and ASCA in inflammatory bowel disease. , 1999, Inflammatory bowel diseases.
[17] D. Jewell,et al. Medical therapy for induction and maintenance of remission in pouchitis: a systematic review. , 1999, Inflammatory bowel diseases.
[18] S. Targan,et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. , 1998, Gastroenterology.
[19] P. Rutgeerts,et al. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease. , 1998, Gastroenterology.
[20] S. Targan,et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role , 1998, Gut.
[21] Albert,et al. Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) 1β and IL‐1 receptor antagonist gene polymorphisms , 1998, European journal of clinical investigation.
[22] J. Nicholls,et al. Perinuclear anti-neutrophil cytoplasmic antibodies in ulcerative colitis after restorative proctocolectomy do not correlate with the presence of pouchitis. , 1998, Scandinavian journal of gastroenterology.
[23] D. Jewell,et al. Outcome of 200 restorative proctocolectomy operations: The John Radcliffe Hospital experience , 1997, The British journal of surgery.
[24] M. Parkes,et al. Cytokine gene polymorphisms in inflammatory bowel disease. , 1996, Gut.
[25] R. Vaughan,et al. Genetic and immunological markers in pouchitis , 1996, European journal of gastroenterology & hepatology.
[26] R. Löfberg,et al. Pouchitis following pelvic pouch operation for ulcerative colitis , 1996, Diseases of the colon and rectum.
[27] S. Targan,et al. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. , 1996, Gastroenterology.
[28] P. Jacquinot,et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease , 1996, Clinical and diagnostic laboratory immunology.
[29] G. Bouma,et al. Evidence for genetic heterogeneity in IBD: 1. The interleukin‐1 receptor antagonist in the predisposition to suffer from ulcerative colitis , 1996, European journal of gastroenterology & hepatology.
[30] N. LaRusso,et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. , 1996, Gut.
[31] F. Cominelli,et al. Interleukin‐1 and interleukin‐1 receptor antagonist in inflammatory bowel disease. , 1996, Alimentary pharmacology & therapeutics.
[32] S. Targan,et al. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. , 1995, The American journal of gastroenterology.
[33] C. Fiocchi,et al. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. , 1995, Journal of immunology.
[34] D. Grennan,et al. Cytokine production by normal human monocytes: inter‐subject variation and relationship to an IL‐1 receptor antagonist (IL‐1Ra) gene polymorphism , 1995, Clinical and experimental immunology.
[35] K. Batts,et al. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. , 1994, Mayo Clinic proceedings.
[36] L. van Lieshout,et al. Pouchitis: result of microbial imbalance? , 1994, Gut.
[37] J. Mansfield,et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. , 1994, Gastroenterology.
[38] L. Hultén,et al. Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch. , 1993, Scandinavian journal of gastroenterology.